doi: 10.1016/s0278-5846(82)80182-6.
Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant
- PMID: 6959196
- DOI: 10.1016/s0278-5846(82)80182-6
Item in Clipboard
Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant
Prog Neuropsychopharmacol Biol Psychiatry.
1982.
Abstract
1. Ten hospitalized, depressive, female patients above the age of 50 have been treated in a 3 week open trial with citalopram, a specific 5-HT-uptake inhibitor. 2. Six full and two partial responders demonstrate a recovery rate within the well known range for tricyclic antidepressant drugs. 3. Early onset of clinical effect and minimal side effects indicate that citalopram is possible a new effective antidepressant.
Similar articles
-
Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171).Acta Psychiatr Scand. 1980 Sep;62(3):236-44. doi: 10.1111/j.1600-0447.1980.tb00611.x. Acta Psychiatr Scand. 1980. PMID: 6935914
-
[Open preliminary study of new antidepressive compound: citalopram].Encephale. 1984;10(3):131-4. Encephale. 1984. PMID: 6594229 French.
-
Citalopram--a specific 5-HT-reuptake inhibitor--as an antidepressant drug: a phase II multicentre trail.Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(3):327-35. doi: 10.1016/s0278-5846(82)80183-8. Prog Neuropsychopharmacol Biol Psychiatry. 1982. PMID: 6959197
-
Clinical experience with serotonin reuptake inhibiting antidepressants.J Clin Psychiatry. 1987 Mar;48 Suppl:26-30. J Clin Psychiatry. 1987. PMID: 2950077 Review.
-
Citalopram--pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity.Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(3):277-95. doi: 10.1016/s0278-5846(82)80179-6. Prog Neuropsychopharmacol Biol Psychiatry. 1982. PMID: 6128769 Review.
Cited by
-
Kinetics of citalopram in elderly patients.Psychopharmacology (Berl). 1985;86(3):253-7. doi: 10.1007/BF00432209. Psychopharmacology (Berl). 1985. PMID: 3929295
-
Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.Drugs. 1991 Mar;41(3):450-77. doi: 10.2165/00003495-199141030-00008. Drugs. 1991. PMID: 1711447 Review.
-
Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.Psychopharmacology (Berl). 1984;83(1):20-7. doi: 10.1007/BF00427416. Psychopharmacology (Berl). 1984. PMID: 6429698
-
Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels.Eur J Clin Pharmacol. 1985;28(5):553-7. doi: 10.1007/BF00544066. Eur J Clin Pharmacol. 1985. PMID: 3899675 Clinical Trial.
-
Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patients.Psychopharmacology (Berl). 1985;87(3):253-9. doi: 10.1007/BF00432703. Psychopharmacology (Berl). 1985. PMID: 3936081 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
